Table 1

Demographic and clinical data of subjects with Parkinson's disease

UPDRSDyskinesia scores
SubjectDBS siteAge (years)PD duration (years)OFFDBSDOPADOPA +DBSOFFDBSDOPADOPA +DBSAnti-PD drugs
(1)Dyskinesia scores collected one year after surgery instead of six months.
DBS, deep brain stimulation; DOPA, dopamine treatment; GPi, globus pallidus internus; OFF, no treatment; STN, subthalamic nucleus.
I (1)STN6118753233250257Carbi/Levodopa, atenolol, levothyroxine
IIGPi4811414030.5280003Carbi/Levodopa, bromocriptine, trihexythenidyl
IIISTN5321856125.5250003Carbi/Levodopa, trihexynidyl
IVGPi758403226.5220050Carbi/Levodopa, amantadine
VGPi611221.51012.55.50000Carbi/Levodopa, amantadine, pergolide, Flomax, Zoloft
VISTN691978501911.50000Carbi/Levodopa, pergolide